An innovative molecular-diagnostic tool using saliva to diagnose and predict risk for periodontal diseases quickly and accurately.

一种创新的分子诊断工具，利用唾液快速准确地诊断和预测牙周疾病的风险。

• 批准号: 10028655
• 金额: $ 34.28万
• 依托单位: CIRCAGENE LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10028655
• 关键词: innovative; molecular; diagnostic; tool; using

CircaGene Ltd is a UK-based _in_**_-_**_vitro_ medical device SME with a core project team of Dr Joanna Wiecek, project lead and microbiome expert, Francois Paillier, bioinformatician and sequencing expert and Jacky Palma, project manager. CircaGene is seeking funding to develop diagnostic software that uses saliva to evaluate oral health and detect periodontal diseases in collaboration withUniversity College London. Its innovative tool will use oral microbiome and metabolite analysis to provide an accurate assessment of oral health and early detection of periodontal diseases. The easily accessible test kit will be suitable for professional and non-specialist use, encouraging individuals to take responsibility for their oral hygiene-related choices.

CircaGene Ltd是一家总部位于英国的体外医疗器械SME，其核心项目团队包括项目负责人兼微生物组专家Joanna Wiecek博士、生物信息学家兼测序专家Francois Paillier和项目经理Jacky Palma。CircaGene正在寻求资金，与伦敦大学学院合作，开发利用唾液评估口腔健康和检测牙周疾病的诊断软件。其创新工具将使用口腔微生物组和代谢物分析来提供口腔健康的准确评估和牙周疾病的早期检测。易于获得的测试工具包将适合专业和非专业人员使用，鼓励个人对他们的口服可卡因相关选择负责。